Rennova Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Rennova Health generated cash of -$16,790,529, which is less than the previous year. Cash used in financing activities reached the amount of $17,087,839 last year. Net change in cash is therefore $8,420.
Cash Flow
| 2012 | -3.10M | 3.32M | 0 |
|---|---|---|---|
| 2013 | -3.83M | 57K | 0 |
| 2014 | -2.59M | -22K | 6K |
| 2016 | -19.86M | 63.27K | 11.04M |
| 2018 | -7.67M | 662.57K | 7.02M |
| 2019 | -13.56M | -658.66K | 14.23M |
| 2020 | -16.79M | -288.89K | 17.08M |
RNVAW Cash Flow Statement (2012 – 2020)
| 2020 | 2019 | 2018 | 2016 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 16.93K | 6.87K | 0 | 77.97K | 4.03M | 7.82M | 7.57M |
Operating activities | |||||||
Net income | -18.33M | -48.03M | -14.02M | -32.61M | -3.31M | -3.92M | -1.42M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 700.99K | 17.01M | 18.82M | 3.04M | 162K | 176K | 9K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 695K | 175K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 695K | 175K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 1.44M | -959.85K | -2.84M | 3.05M | 102K | -250K | 0 |
Inventories | 168.92K | 156.48K | 234.19K | -6.36M | -4.41M | -6.97M | 0 |
Accounts payable | 1.44M | 5.87M | 4.07M | -905.63K | 101K | -483K | -261K |
Cash generated by operating activities | -16.79M | -13.56M | -7.67M | -19.86M | -2.59M | -3.83M | -3.10M |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -288.89K | -127 | -213.10K | -36.72K | -22K | -119K | -4K |
Acquisitions Net | 0 | -658.53K | -634.72K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -288.89K | -658.66K | 662.57K | 63.27K | -22K | 57K | 3.32M |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -684 | 0 | 0 | 0 | -1.43M | -4.03M | -7.82M |
Repayments of term debt | -7.03M | 0 | -8.60M | -15.34M | 0 | 0 | 0 |
Cash used in financing activities | 17.08M | 14.23M | 7.02M | 11.04M | 6K | 0 | 0 |
Net Change In Cash | 8.42K | 10.06K | 6.87K | 0 | -2.60M | -3.78M | 245K |
Cash at end of period | 25.35K | 16.93K | 6.87K | 77.97K | 1.43M | 4.03M | 7.82M |
| Data source | Data source | Data source | Data source | Data source | Data source |